Cover Image

Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Dawn C. Matthews, Jefferson W. Kinney, Aaron Ritter, Randolph D. Andrews, Erin N. Toledano Strom, Ana S. Lukic, Lauren N. Koenig, Carolyn Revta, Howard M. Fillit, Kate Zhong, Babak Tousi, James B. Leverenz, Howard H. Feldman, Jeffrey Cummings
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advancing patient care with tau pathology biomarkers
by: Howard M Fillit
Published: (2025)

Inflammation clinical trial in mild to moderate Alzheimer's disease: TSPO‐PET results
by: Belen Pascual, et al.
Published: (2025)

FDG PET/CT in large vessel vasculitis
by: Karan Bir Singh, et al.
Published: (2024)

Analysis of the posterior cingulate cortex with [18F]FDG-PET and Naa/mI in mild cognitive impairment and Alzheimer’s disease. Correlations and differences between the two methods
by: Artur M.N. Coutinho
Published: (2015)

Effect of image‐processing and statistical harmonization methods on tau PET cognitive group separability for multisite cross‐sectional and longitudinal studies using 18 F‐Flortaucipir PET
by: Weiquan Luo, et al.
Published: (2025)

Prevalence of hypometabolism in AD‐related regions in real‐world FDG‐PET of the brain
by: Trent Schwartz, et al.
Published: (2024)

Prevalence of hypometabolism in AD‐related regions in real‐world FDG‐PET of the brain
by: Trent Schwartz, et al.
Published: (2024)

HearCog Trial‐ Findings from FDG‐PET
by: Heidi Espedal, et al.
Published: (2025)

Use of FDG ‐ PET in Balamuthia mandrillaris Amebic Encephalitis
by: Kristoffer E. Leon, et al.
Published: (2025)

Muscular polyarteritis nodosa detected by FDG‐PET/CT
by: Yoshinori Taniguchi, et al.
Published: (2024)

Clinical use of tau PET in Aβ PET positive individuals: a case series
by: Vitor Hugo Machado, et al.
Published: (2024)

The prevalence of tau‐PET positivity in aging and dementia
by: Emma M. Coomans, et al.
Published: (2024)

Longitudinal progression and harmonization of tau‐PET tracers
by: Guilherme Bauer‐Negrini, et al.
Published: (2025)

Longitudinal progression and harmonization of tau‐PET tracers
by: Guilherme Bauer‐Negrini, et al.
Published: (2025)

The role of combined FDG and SST PET / CT in neuroendocrine tumors
by: Martina Di Franco, et al.
Published: (2024)

FDG‐PET patterns associate with survival in patients with prion disease
by: Nick Corriveau‐Lecavalier, et al.
Published: (2024)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
by: Kay Jann, et al.
Published: (2025)

Quantitative brain 18F‐FDG PET/CT analysis in seronegative autoimmune encephalitis
by: Samantha N. Roman, et al.
Published: (2024)

Universal tau PET scale (Uniτ) – The HEAD Study
by: Guilherme Povala, et al.
Published: (2024)

Universal tau PET scale (Uniτ) – The HEAD Study
by: Guilherme Povala, et al.
Published: (2024)

Differing network patterns of functional connectivity and amyloid PET between tau PET subtypes
by: Peter R Millar, et al.
Published: (2025)

Cerebrospinal fluid proteomics identifies biomarkers for discriminating amyloid PET and tau PET stages
by: Zhibo Wang, et al.
Published: (2024)

Characterization of the heterogeneity of amyloid‐PET‐negative patients with a clinical diagnosis of sporadic early‐onset AD: an FDG‐PET study in the LEADS cohort
by: Julien Lagarde, et al.
Published: (2024)

Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology
by: Jagan A. Pillai, et al.
Published: (2024)

Association of 18F‐flortaucipir PET with tau neuropathology in AD and other neurodegenerative disorders
by: Agathe Vrillon, et al.
Published: (2024)

Plasma p‐tau217 outperforms [18F]FDG‐PET in identifying biological Alzheimer’s disease in atypical and early‐onset dementia
by: Kely Monica Quispialaya Socualaya, et al.
Published: (2024)

Multimodality Imaging Approaches in Alzheimer’s disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
by: Chetsadaporn Promteangtrong
Published: (2015)

Determination of unscaled blood input for human dynamic FDG brain PET
by: Terrell, William, et al.
Published: (2025)

1–2–3‐4 Sign FDG PET Sign in Sarcoidosis
by: Luke Cassidy, et al.
Published: (2026)

Clinical Correlates of FDG PET and DaT Factors in Heterogenous Clinical Sample
by: Jessica May Pommy, et al.
Published: (2025)

Clinical Correlates of FDG PET and DaT Factors in Heterogenous Clinical Sample
by: Jessica May Pommy, et al.
Published: (2025)

18‐ FDG PET in the Evaluation of Therapeutic Response of Necrotizing Otitis Externa
by: Lucie Lécolier, et al.
Published: (2025)

18F‐FDG PET/CT in paediatric Staphylococcus aureus bacteraemia
by: Karan Bir Singh, et al.
Published: (2024)

Prediction of neuropathology using the FDG‐PET based patient similarity network
by: Gemeng Zhang, et al.
Published: (2025)

18F‐FDG PET/CT findings of paratesticular alveolar rhabdomyosarcoma
by: Xueqi Chen, et al.
Published: (2024)

Progressive Dysexecutive Syndrome (PDS) due to Alzheimer’s Disease: Genetic and Neuroinflammatory Correlates in a Rapidly Progressive Case
by: Aaron Ritter, et al.
Published: (2024)

Patchy FDG uptake on FDG PET/CT in a patient with vasculitic neuropathy in restricted lower‐limb vasculitis
by: Hiroshi Sakiyama, et al.
Published: (2024)

Longitudinal multicenter head‐to‐head harmonization of tau‐PET tracers
by: Firoza Z Lussier, et al.
Published: (2025)

PSMA PET/CT Incidental Detection of Tumor Thrombus From Unsuspected Renal Cell Carcinoma and Comparison with FDG PET/CT
by: William Y. Raynor, et al.
Published: (2025)

FDG‐PET and Amyloid PET scans: benefits beyond Alzheimer´s Disease. It´s really useful in daily practice? Clinical case review
by: Shenda Orrego, et al.
Published: (2024)